Anti Human RAGE Monoclonal Antibody (Clone No. 1C5)

Product#: KG134
Ships in 1-2 weeks

Anti Human RAGE Monoclonal Antibody (Clone No. 1C5)

General information 

Cat. No. KG134
Primary Source HGNC 320
Type Monoclonal
Concentration 0.25 mg/mL
ContentsVolume 50 μg(200 μL/vial)
Recombinant protein of soluble form human RAGE
Purification ProteinG
Source Serum Free Medium
Myeloma P3U1
Clone number 1C5
Isotype IgG1 κ
Buffer PBS [containing 2% Block Ace as a stabilizer,0.1% Proclin as a bacteriostat]
Cross Reactivity Not yet tested in order species
Label Unlabeled
Storage Store at - 20℃ long term, store at 4℃ short term. Avoid repeated freeze-thaw cycles.
Application :ELISA, WB, ICC, FCM











Not tested


Not tested


Not tested

Not tested




RAGE (receptor for AGEs, advanced glycation end products) is an around 35 kDa multiligand receptor classified as an immunoglobulin superfamily cell surface molecule. RAGE is found in endothelium, smooth muscle cells, cardiac myocytes, neural tissue, and mononuclear cells and two major truncated forms of RAGE have been also identified (N-terminally truncated, C- terminally truncated). RAGE acts as a couter-receptor for not only AGEs, but also high mobility group box1 (HMGB1), S100/calgranulins, and amyloid-peptides. Intracellular signaling pathways induced by RAGE include the activation of Cdc42/Rac, MAP kinase, NF-KB. The C-terminally truncated soluble form of RAGE can bind ligands including AGEs and antagonize RAGE signaling in vitro and in vivo

RAGE plays important role for immflammation, diabetes, diabetic complications such as nephropathy, vascular injury and Alzheimer's disease. Several clinical studiese have demonstrated that the strong association of RAGE expression with malignant potential of various cancers. It has been showed that engagement of RAGE by HMGB1 plays an important role in regulating the tumor formation, growth, metastasis. It is also suggested that glyceraldehyde- and glycolaldehyde-derived AGEs may be significantly involved in the growth and invasion of melanoma through interactions with RAGE. 

This antibody is specific to RAGE and will be useful to research for cancer, chromic diseases associated with aging and diabetic complications. 




  1. Nakano,K. et al.: Abnormally high activity of 3-hydroxyanthranilate 3,4-dioxygenase in brain of epilepsy-prone El mice Brain Res. 1992 572 (1-2), 1-4 
  2. Eastman,C.L. et al.: Differential expression of the astrocytic enzymes 3-hydroxyanthranilic acid oxygenase, kynurenine aminotransferase and Epilepsy Res. glutamine synthetase in seizure-prone and non-epileptic mice 1994 18 (3), 185-194
  3. Nakagawa,Y. et al.: Increased expression of 3-hydroxyanthranilate 3,4-dioxygenase gene in brain of epilepsy-prone El mice Brain Res. 1998 Mol. Brain Res. 58 (1-2), 132-137


Aliases for AGER Gene

  • Advanced Glycosylation End-Product Specific Receptor 2 3 5
  • RAGE 2 3 4
  • Advanced Glycosylation End Product-Specific Receptor 3 4
  • SCARJ1 2 3
  • SRAGE 2 3
  • Receptor For Advanced Glycation End-Products Variant 20 3
  • Receptor For Advanced Glycosylation End Products 4
  • Receptor For Advanced Glycation End-Products 2
  • AGER 5



Quality Rating
Value Rating
Style Rating